Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...

Administering the monoclonal antibody sotrovimab intramuscularly was noninferior to the intravenous (IV) route for high-risk COVID patients, a researcher said. The risk difference between groups for ...